JNJ

186.79

+0.34%↑

ABT

125.77

+1.66%↑

TMO

565.15

+0.26%↑

ISRG

538.71

-0.99%↓

DHR

213.79

-0.14%↓

JNJ

186.79

+0.34%↑

ABT

125.77

+1.66%↑

TMO

565.15

+0.26%↑

ISRG

538.71

-0.99%↓

DHR

213.79

-0.14%↓

JNJ

186.79

+0.34%↑

ABT

125.77

+1.66%↑

TMO

565.15

+0.26%↑

ISRG

538.71

-0.99%↓

DHR

213.79

-0.14%↓

JNJ

186.79

+0.34%↑

ABT

125.77

+1.66%↑

TMO

565.15

+0.26%↑

ISRG

538.71

-0.99%↓

DHR

213.79

-0.14%↓

JNJ

186.79

+0.34%↑

ABT

125.77

+1.66%↑

TMO

565.15

+0.26%↑

ISRG

538.71

-0.99%↓

DHR

213.79

-0.14%↓

Search

Retractable Technologies Inc

Closed

SectorHealthcare

0.82 -3.53

Overview

Share price change

24h

Current

Min

0.82

Max

0.86

Key metrics

By Trading Economics

Income

10M

-87K

Sales

2.2M

10M

EPS

-0.005

Profit margin

-0.837

Employees

221

EBITDA

10M

1.8M

Dividends

By Dow Jones

Next Earnings

12 lis 2025

Market Stats

By TradingEconomics

Market Cap

1.9M

26M

Previous open

4.35

Previous close

0.82

News Sentiment

By Acuity

29%

71%

69 / 373 Ranking in Healthcare

Retractable Technologies Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

4 lis 2025, 23:57 UTC

Earnings

Naver's Third-Quarter Earnings Rose on AI Push

4 lis 2025, 23:10 UTC

Acquisitions, Mergers, Takeovers

Kennedy-Wilson Gets Acquisition Proposal From CEO, Fairfax Financial

4 lis 2025, 23:48 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

4 lis 2025, 23:48 UTC

Market Talk

Nikkei May Fall After U.S. Tech Stock Weakness -- Market Talk

4 lis 2025, 23:37 UTC

Market Talk

Gold Edges Higher on Possible Technical Recovery -- Market Talk

4 lis 2025, 23:30 UTC

Earnings

Itau Unibanco 3Q Net BRL33.7B >ITUB

4 lis 2025, 23:25 UTC

Earnings

Naver 3Q Net Profit Beat FactSet-Compiled Consensus

4 lis 2025, 23:25 UTC

Earnings

Naver 3Q Net KRW734.70B Vs. Net KRW530.10B >035420.SE

4 lis 2025, 23:24 UTC

Earnings

Naver 3Q Oper Pft KRW570.60B Vs. Pft KRW525.30B >035420.SE

4 lis 2025, 23:23 UTC

Earnings

Naver 3Q Rev KRW3.138T Vs. KRW2.716T >035420.SE

4 lis 2025, 23:06 UTC

Earnings

Review & Preview: Tech Check -- Barrons.com

4 lis 2025, 22:52 UTC

Earnings

AMD Reports Sharply Higher Profits, Sales -- 3rd Update

4 lis 2025, 22:33 UTC

Earnings

AMD Beats Earnings. The Stock Still Slides. -- Barrons.com

4 lis 2025, 22:29 UTC

Earnings

Ashland 4Q Adj EPS $1.08 >ASH

4 lis 2025, 22:29 UTC

Earnings

Ashland Sees FY26 Adjusted EPS Up More Than Double Digits >ASH

4 lis 2025, 22:28 UTC

Earnings

Ashland Sees FY26 Sales $1.84B-$1.91B >ASH

4 lis 2025, 22:27 UTC

Earnings

Ashland 4Q Cont Ops EPS 73c >ASH

4 lis 2025, 22:27 UTC

Earnings

Ashland 4Q EPS 71c >ASH

4 lis 2025, 22:27 UTC

Earnings

Ashland 4Q Sales $478M >ASH

4 lis 2025, 22:23 UTC

Earnings

Ovintiv 3Q EPS 57c >OVV

4 lis 2025, 22:19 UTC

Market Talk

Canada Budget: Snap Election Talk Might Cool -- Market Talk

4 lis 2025, 22:16 UTC

Earnings

AMD Reports Sharply Higher Profits, Sales -- 2nd Update

4 lis 2025, 22:14 UTC

Acquisitions, Mergers, Takeovers

Kennedy-Wilson Board Forms Special Committee to Evaluate Proposal

4 lis 2025, 22:13 UTC

Acquisitions, Mergers, Takeovers

Consortium: Not Interested in Selling Kennedy-Wilson Shares to Another Party

4 lis 2025, 22:13 UTC

Acquisitions, Mergers, Takeovers

Consortium: Able to Finance a Deal With Available Liquidity

4 lis 2025, 22:12 UTC

Acquisitions, Mergers, Takeovers

Consortium Owns About 31% of Kennedy-Wilson Stock on As-Converted Basis

4 lis 2025, 22:11 UTC

Earnings

Private-Credit Earnings Ease Investor Concern Over Market's Health -- Update

4 lis 2025, 22:11 UTC

Acquisitions, Mergers, Takeovers

Kennedy-Wilson Gets Proposal From CEO William McMorrow and Fairfax Financial Holdings

4 lis 2025, 22:10 UTC

Acquisitions, Mergers, Takeovers

Pfizer, Novo Nordisk Escalate Bidding War for Weight-Loss Drug Startup -- 2nd Update

4 lis 2025, 22:07 UTC

Earnings

Kinross Gold Raises Dividend to $0.035 >K.T

Peer Comparison

Price change

Retractable Technologies Inc Forecast

Rating Consensus

By TipRanks

0 ratings

0

Buy

0

Hold

0

Sell

Sentiment

By Acuity

69 / 373 Ranking in Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Retractable Technologies Inc

Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributor; international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.
help-icon Live chat